1-(Pyridin-4-ylmethyl)-1H-pyrazol-4-amine, 95.0%, 250mg

2-Chloro-4-fluoro-6-methylaniline, 95.0%, 500mg

2-Cyclopenten-1-one, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 95.0%, 100mg

3-Fluoro-2-hydroxybenzamide, 97%, 100mg

Sample tub Type 2117, 1000 ml, 4 Piece(s)

2,2'-(3-Bromothiophene-2,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 98%, 10g

(3-((Tetrahydro-2H-pyran-2-yl)oxy)phenyl)boronic acid, 95.0%, 250mg

Dabigatran>95.0%(HPLC)500mg

(4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt, 95.0%, 5g

DIHYDRORESVERATROL, 95%, 1g

3,6-Dichloro-2-methoxybenzoic acid, 95.0%, 500g

Pentaethylene glycol monododecyl ether, 98%, 100mg

3-Bromo-6-fluoro-1H-indazole, 95.0%, 10g